19 Aug 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/08/19/2932052/0/en/PharmaTher-s-Sairiyo-Therapeutics-Receives-Approval-to-Initiate-a-Phase-1-Human-Clinical-Trial-of-PD-001-Reformulated-Cepharanthine.html
15 May 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/05/15/2882391/0/en/PharmaTher-s-Sairiyo-Therapeutics-Submits-Clinical-Trial-Application-for-Phase-1-Study-of-Patented-Reformulated-Cepharanthine.html
01 May 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/05/01/2873176/0/en/PharmaTher-s-Sairiyo-Therapeutics-Completes-Clinical-and-Regulatory-Package-for-Phase-1-Study-of-Patented-Reformulated-Cepharanthine.html
LOOKING FOR A SUPPLIER?